@FierceBiotech: Cubist makes Euro landfall with a $400M purse for antibiotics R&D. More | Follow @FierceBiotech
@JohnCFierce: FYI, I'm setting up some meets after the executive panel in Boston next month. Details | Follow @JohnCFierce
@DamianFierce: The @FierceBiotech Fierce 15 unveiling is happening live (and live-streamed) on Monday in Boston at #BPA14. Story | Follow @DamianFierce
@EmilyMFierce: Antibiotics R&D to get critical lift by executive order, Obama advisory group. Article | Follow @EmilyMFierce
> Calithera Biosciences has set terms for an $84 million IPO, looking to accelerate its treatments designed to shrink tumors by targeting their metabolisms. More
> Long-troubled biotech Allozyne is finally no more, Xconomy reports, as its parts have large been sold off to the likes of AstraZeneca's ($AZN) MedImmune. Story
> Biotech investor Frazier Healthcare has recruited former Incline Therapeutics and Cadence Pharmaceuticals ($CADX) exec David Socks to join its ranks as a venture partner. News
Medical Device News
@FierceMedDev: UDI architect shares compliance tips on eve of regulation's first deadline. More | Follow @FierceMedDev
@MichaelGFierce: Vaxxas' nanopatch garners WHO support in search of #polio vax application. Story | Follow @MichaelGFierce
@VarunSaxena2: Court ruling against FDA should enable more combination products to be classified as devices. Article | Follow @VarunSaxena2
@EmilyWFierce: San Francisco startup stirring up buzz for chicken egg facsimile, cataloging plant proteins to create new food model. Story | Follow @EmilyWFierce
> Apple HealthKit delayed by bug as major EHR players commit. Story
> British startup launches crowdfunding effort for 3-D printed orthotic devices. Article
Pharma News
@FiercePharma: Top-read pharma news Thurs: Put a lid on 'Low-T' drug use, FDA panel advises, threatening AbbVie, Lilly meds. Story | Follow @FiercePharma
@EricPFierce: Potentially bad news for Amphastar and its $155.7M deal if Sanofi makes insulin for Mannkind. Story via FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: ICYMI: Protein Sciences nabs stake in diabetes vax developer Diamyd. More from FierceVaccines | Follow @CarlyHFierce
> GSK China scandal resolved with $500M fine and suspended jail sentence. Story
> Europe approves Gilead's cancer drug Zydelig amid challenging pricing environment. Article